|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02480 LUZHU BIOTECH-B
Nominal 
22.150 -0.100 (-0.449%) | 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 0 | -- | 0 | 0 |
| Cost of Sales | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | (551,546) | (441,077) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | |
| Other Non-operating Items | (26,459) | 22.825% | (21,542) | (3,126) | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | |
| Profit / (Loss) before Taxation | (249,350) | -65.615% | (725,180) | (539,357) | |
| Taxation | 0 | -- | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | |
| Others | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (249,350) | -65.615% | (725,180) | (539,357) | |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (5,165) | -- | 473 | 562 |
| Depreciation & Amortisation | 16,108 | 62.970% | 9,884 | 6,542 |
| Directors' Emoluments | 40,546 | -48.439% | 78,637 | 46,294 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | |
| EPS (cts) | -125.000 | -74.900% | -498.000 | -- |
| DPS (cts) | 0.000 | -- | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- |
| Cash flow per share ($) | (0.955) | -- | (0.531) | -- |
| NBV per share ($) | 5.041 | -- | -- | -- |
| Remarks: | Real time quote last updated: 27/12/2024 14:46 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -109,938,000 |
| %Change | 38.545% |
| EPS / (LPS) | RMB -0.540 |
| NBV Per Share (¥) | RMB 4.664 |